Back to Business

Tenax Therapeutics CEO Christopher Giordano acquires $20,087 in shares

Business September 16, 2026 at 3:01 AM

Tenax Therapeutics CEO Christopher Giordano acquires $20,087 in shares

Investing.com

Read at Investing.com

More Stories

Asian stocks edge higher as Fed decision looms, oil rally pauses

Asian stocks edge higher as Fed decision looms, oil rally pauses

🇺🇸 Investing.com 18m ago

Chinese investors rush into US stocks as Beijing opens wider path overseas

Chinese investors rush into US stocks as Beijing opens wider path overseas

🇺🇸 Investing.com 20m ago

Why is Trip.com stock rising today?

Why is Trip.com stock rising today?

🇺🇸 Investing.com 24m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play